Clinical trial Recruiting at 1 site Interventional Ages 12 to 100

Gender Inclusive Sexuality Talks for Parents and Teens

Official title: Parents ASSIST for All LGBTQ Youth (Hillman)

Run by University of Pennsylvania · NCT07825571 · Data updated 2026-11-12

This trial tests the GIST program to help parents talk with transgender, gender-diverse, lesbian, or bisexual female youth about sexuality at home.

Quick facts

Study typeInterventional
Ages12 Years to 100 Years
SexAll
Enrollment300 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 30, 2027
Study endsDecember 30, 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT07825571 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking parent–youth dyads in the United States, where the youth identifies as transgender, gender diverse, lesbian, or bisexual female and is between 12 and 18 years old.

Probably not a fit

Youth or parents without interest or access to online interventions or those not meeting eligibility may not experience benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 300 parent–youth dyads to evaluate a 5-session online program that trains parents to discuss sexuality in an inclusive way as transgender or sexual minority identities emerge. The study will compare the GIST program to a control condition, focusing on improving the quality and frequency of parent–youth communication about sexuality and related health topics. Outcomes include changes in mental health symptoms for both parents and youth and changes in dyadic health behaviors. Participants include youths aged 12–18 who identify as transgender, gender diverse, lesbian, or bisexual female, and their English-speaking parents in the United States. The study is led by the University of Pennsylvania with location at Penn Nursing in Philadelphia, and aims to provide scalable guidance for families navigating gender and sexuality discussions at home.

Why it matters

Potential benefit: If successful, families may experience better communication about sexuality and improved mental health and health behaviors for both parents and youth.

How similar studies have gone: Previous work suggests that parent–child sexuality communication interventions can improve dialogue quality and some health outcomes, but this specific GIST program is novel in its online, multi-session format for this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Youth participants are:

identify as transgender or gender diverse, or lebian or bisexual female be between ages 12-18 years able to comprehend spoken English resides in the United States consents or assents to study participation

Parent participants are:

the parent, legal guardians, legal custodians (hereinafter "parent") of index youth age 18 or older able to comprehend spoken English resides in the United States consents to study participation consents to their child's study participation

Exclusion Criteria:

Excluded youth participants are:

non-transgender or gender diverse or lesbian or bisexual female youth

Excluded participants are:

parents whose child does not meet eligibility criteria

Where it's running

  • Penn Nursing
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.